New Metabolic Alterations and A Predictive Marker Pipecolic Acid in Sera for Esophageal Squamous Cell Carcinoma
- Author:
Liu LEI
1
;
Wu JIA
;
Shi MINXIN
;
Wang FENGYING
;
Lu HAIMIN
;
Liu JIBING
;
Chen WEIQIN
;
Yu GUANZHEN
;
Liu DAN
;
Yang JING
;
Luo QIN
;
Ni YAN
;
Jin XING
;
Jin XIAOXIA
;
Chen WEN-LIAN
Author Information
1. Department of Thoracic Surgery,The Affiliated Tumor Hospital of Nantong University,Nantong 226361,China
- Keywords:
Esophageal squamous cell carcinoma;
Serum metabolome;
Esophagectomy;
Predictive potential;
Pipecolic acid
- From:
Genomics, Proteomics & Bioinformatics
2022;20(4):670-687
- CountryChina
- Language:Chinese
-
Abstract:
Esophageal squamous cell carcinoma(ESCC)is a major histological subtype of esopha-geal cancer with a poor prognosis.Although several serum metabolomic investigations have been reported,ESCC tumor-associated metabolic alterations and predictive biomarkers in sera have not been defined.Here,we enrolled 34 treatment-naive patients with ESCC and collected their pre-and post-esophagectomy sera together with the sera from 34 healthy volunteers for a metabo-lomic survey.Our comprehensive analysis identified ESCC tumor-associated metabolic alterations as represented by a panel of 12 serum metabolites.Notably,postoperative abrosia and parenteral nutrition substantially perturbed the serum metabolome.Furthermore,we performed an examina-tion using sera from carcinogen-induced mice at the dysplasia and ESCC stages and identified three ESCC tumor-associated metabolites conserved between mice and humans.Notably,among these metabolites,the level of pipecolic acid was observed to be progressively increased in mouse sera from dysplasia to cancerization,and it could be used to accurately discriminate between mice at the dysplasia stage and healthy control mice.Furthermore,this metabolite is essential for ESCC cells to restrain oxidative stress-induced DNA damage and cell proliferation arrest.Together,this study revealed a panel of 12 ESCC tumor-associated serum metabolites with potential for monitor-ing therapeutic efficacy and disease relapse,presented evidence for refining parenteral nutrition composition,and highlighted serum pipecolic acid as an attractive biomarker for predicting ESCC tumorigenesis.
